FDA Approves Fixed-Dose Ophthalmic Spray for Mydriasis
The approval, granted to Eyenovia, Inc, represents the first-approved fixed-dose combination of tropicamide and phenylephrine for inducing mydriasis for diagnostic procedures and short-term pupil dilation.
Source: hcplive.com